Combination therapy for the prophylaxis and/or treatment of benign prostatic hyperplasia

摘要

A combination therapy for the prophylaxis and/or treatment of benign prostatic hyperplasia in susceptible warm-blooded animals which comprises administering a combination of two or more compounds selected from the group consisting of an inhibitor of 5&agr;-reductase activity, an anti-estrogen, an inhibitor of aromatase activity, an inhibitor of 17&bgr;-hydroxysteroid dehydrogenase activity and, in some cases, an anti-androgen and/or an LHRH agonist. Pharmaceutical compositions useful for such treatment and pharmaceutical kits containing such compositions are disclosed.